Parvovirus test kit AESKULISA®

for serologyIgAIgG

AESKULISA® for qualitative and quantitative demonstration of IgA, IgG, or IgM antibodies directed against a range of different pathogens supporting a reliable diagnosis of infectious diseases. Immunoassays are important in routine laboratory services for identification of antibodies in serum or plasma specimens. AESKULISA® (AESKU Enzyme-Linked Immunosorbent Assay) is a test format particularly suited for the qualitative and quantitative determination of specific IgA, IgG, or IgM antibodies directed against a range of different pathogens. The following AESKULISA® tests are available order to support the diagnosis of infectious diseases. All assays are calibrated according to our clinically well-characterized, internal Quality Control panels and to all of the latest international standards. It ensures the reliability and reproducibility of our AESKULISA® kits. Intended Use: The AESKULISA Parvovirus B19 IgG is a qualitative and quantitative immunoassay for the demonstration of human IgG antibodies in serum or plasma directed against Parvovirus B19. The AESKULISA Parvovirus B19 IgG serves for confirmation of a contact with the pathogen and supports in immune status determination. Recombinant Antigens: Virus-like Particels (VLPs) composed of recombinant VP2 produced in baculovirus-infected insect cells Native Antigens: n.a. Kit Configuration: - Single - G Cut Off: - 4-6 Range: - 3 - 100 IU/ml Standard: - WHO 01/602